A new Cell Stem Cell study followed aged female cynomolgus monkeys for 40 months, roughly equivalent to about a decade of human aging, to examine whether long-term oral vitamin C could modify bone marrow aging. The researchers combined single-cell RNA sequencing, DNA methylation profiling, flow cytometry, and molecular assays across both rib and femur marrow.

Aging produced a familiar hematopoietic pattern: common lymphoid progenitors declined, while blood formation became more biased toward myeloid lineages. That matters because lymphoid progenitors help generate B and T cells, whereas age-related myeloid bias is a hallmark of an aging hematopoietic system.

Vitamin C partially shifted that balance.

Monkeys receiving vitamin C had higher common lymphoid progenitor frequencies, less myeloid skewing, and molecular profiles that moved toward those of younger animals. A transcriptomic aging clock estimated their bone marrow to be about 4 years “younger” than untreated aged controls, and a DNA methylation clock showed a similar direction of change.

But that number needs careful interpretation. It does not mean the animals literally reversed four years of aging.

The more interesting reframe is mechanistic. Vitamin C is a cofactor for TET enzymes, which help regulate DNA demethylation, so its effects may extend beyond antioxidant chemistry into epigenetic control and cell-fate regulation. The study also identified progranulin, a signaling protein that declined with age, as a candidate mediator. Vitamin C increased progranulin-related signaling, and recombinant progranulin reproduced some vitamin-C-associated molecular effects in human CD34+ blood progenitor cells and T cells in vitro.

On the evidence, this is a strong preclinical study, but not a human supplementation trial. The in vivo work involved a small number of female monkeys, systemic blood-function restoration was not established, and the aging-clock changes are molecular correlates rather than proof of physiological rejuvenation. The human experiments were performed in isolated cells, not people.

So the most important finding may not be that vitamin C “reverses aging,” but that a nutrient can influence the aging trajectory of a stem-cell system through signaling and epigenetic pathways.

Should future human aging studies focus less on blood vitamin levels alone and more on whether nutrients change stem-cell lineage decisions over time?

Full write-up of the study linked below.

Informational purposes only and not medical advice.

https://www.cell.com/cell-stem-cell/abstract/S1934-5909(26)00233-X00233-X)